Skip to main content Skip to section navigation Skip to footer

Processa Pharmaceuticals, Inc.

  • Home
  • About
    • Overview
    • Partnering
    • Management Team
    • Board of Directors
  • Product Pipeline
    • Overview
    • PCS3117
    • PCS6422
    • PCS11T
    • Publications
  • Our Clinical Trials
    • Overview
    • PCS6422
  • News & Media
    • Press Releases
    • Presentations
    • Events
    • In The News
  • Investors
    • Overview
    • News & Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
  • Contact
  • Careers

Presentations

News & Media

News & Media

  • Press Releases
  • Presentations
  • Events
  • In The News
Applying FDA’s Project Optimus to the Development of Next Generation Chemotherapy Treatment of Rare Cancers – WODC May 24, 2023
May 24, 2023

Applying FDA’s Project Optimus to the Development of Next Generation Chemotherapy Treatment of Rare Cancers – WODC May 24, 2023

Digestive Disease Week Presentation
May 9, 2023

Digestive Disease Week Presentation

Oppenheimer Annual Conference Presentation
Mar 14, 2023

Oppenheimer Annual Conference Presentation

Biotech Showcase Presentation
Jan 16, 2023

Biotech Showcase Presentation

Corporate Update Presentation
Dec 21, 2022

Corporate Update Presentation

Corporate Update Presentation
Nov 8, 2022

Corporate Update Presentation

Corporate Update Presentation
Aug 12, 2022

Corporate Update Presentation

Clinical Pipeline Update
May 12, 2022

Clinical Pipeline Update

Clinical Pipeline Update
Mar 30, 2022

Clinical Pipeline Update

Clinical Pipeline Update
Mar 17, 2022

Clinical Pipeline Update

RSS
  • Previous
  • 1
  • 2
  • 3
  • Next
Twitter LinkedIn
©2025 Processa Pharmaceuticals, Inc. All Rights Reserved.
Privacy Policy Disclaimer Sitemap Manage Cookie Preferences